A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

BACKGROUND: Lysergic acid diethylamide (LSD) is an ergot alkaloid derivative with psychedelic properties that has been implicated in the management of persistent pain. Clinical studies in the 1960s and 1970s have demonstrated profound analgesic effects of full doses of LSD in terminally ill patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaekers, Johannes G, Hutten, Nadia, Mason, Natasha L, Dolder, Patrick, Theunissen, Eef L, Holze, Friederike, Liechti, Matthias E, Feilding, Amanda, Kuypers, Kim PC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054163/
https://www.ncbi.nlm.nih.gov/pubmed/32842825
http://dx.doi.org/10.1177/0269881120940937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054163/
https://www.ncbi.nlm.nih.gov/pubmed/32842825
http://dx.doi.org/10.1177/0269881120940937

Ejemplares similares